Charles Schwab Investment Management Inc. Has $349,000 Holdings in Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Charles Schwab Investment Management Inc. trimmed its position in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 8.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 153,037 shares of the company’s stock after selling 14,260 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 0.18% of Stereotaxis worth $349,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in the company. SG Americas Securities LLC boosted its stake in Stereotaxis by 39.2% during the 4th quarter. SG Americas Securities LLC now owns 26,360 shares of the company’s stock valued at $60,000 after purchasing an additional 7,417 shares during the period. Jane Street Group LLC boosted its position in shares of Stereotaxis by 26.9% in the third quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock valued at $61,000 after acquiring an additional 6,313 shares during the period. Wealth Effects LLC grew its stake in shares of Stereotaxis by 11.7% in the fourth quarter. Wealth Effects LLC now owns 86,060 shares of the company’s stock worth $196,000 after acquiring an additional 9,000 shares during the last quarter. Barclays PLC grew its stake in shares of Stereotaxis by 449.9% in the third quarter. Barclays PLC now owns 101,953 shares of the company’s stock worth $208,000 after acquiring an additional 83,412 shares during the last quarter. Finally, Kovack Advisors Inc. increased its position in Stereotaxis by 8.0% during the fourth quarter. Kovack Advisors Inc. now owns 133,792 shares of the company’s stock worth $305,000 after acquiring an additional 9,917 shares during the period. Institutional investors own 45.35% of the company’s stock.

Stereotaxis Trading Down 2.8 %

STXS opened at $1.71 on Wednesday. The company’s 50 day moving average price is $2.12. The company has a market capitalization of $144.89 million, a PE ratio of -6.11 and a beta of 1.54. Stereotaxis, Inc. has a 1 year low of $1.66 and a 1 year high of $3.29.

Insiders Place Their Bets

In other Stereotaxis news, Director Paul J. Isaac bought 23,299 shares of Stereotaxis stock in a transaction dated Thursday, March 6th. The shares were acquired at an average cost of $1.81 per share, with a total value of $42,171.19. Following the acquisition, the director now directly owns 49,066 shares of the company’s stock, valued at $88,809.46. The trade was a 90.42 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 18.52% of the company’s stock.

About Stereotaxis

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.